» Authors » Abiodun Omokehinde Eseola

Abiodun Omokehinde Eseola

Explore the profile of Abiodun Omokehinde Eseola including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 26
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson T, Adeyemi O, Adegboyega A, Olomu S, Enokela F, Ibrahim S, et al.
J Biomol Struct Dyn . 2022 Oct; 41(18):9013-9021. PMID: 36310100
The development of resistance to conventional antimalarial therapies, along with the unfavorable impact of the COVID-19 pandemic on the global malaria fight, necessitates a greater focus on the search for...
2.
Adeyemi O, Eseola A, Plass W, Kato K, Otuechere C, Awakan O, et al.
Chem Biol Interact . 2021 Sep; 349:109676. PMID: 34592218
Background: Therapeutic options for toxoplasmosis are limited. This fact underscores ongoing research efforts to identify and develop better therapy. Previously, we reported the anti-parasitic potential of a new series of...
3.
Adeyemi O, Molefe-Nyembe N, Eseola A, Plass W, Shittu O, Yunusa I, et al.
Yale J Biol Med . 2021 Jul; 94(2):199-207. PMID: 34211341
The spp. cause animal and human trypanosomiasis characterized with appreciable health and economic burden mostly in developing nations. There is currently no effective therapy for this parasitic disease, due to...
4.
Adeyemi O, Eseola A, Plass W, Otuechere C, Elebiyo T
Biochem Biophys Res Commun . 2020 Jun; 529(1):23-27. PMID: 32560814
Background: Our previous reports demonstrated the prospects of a new series of imidazoles as a source of alternative anti-parasite treatments, thus warranting further studies that include toxicity profiling. Objective: In...
5.
Adeyemi O, Eseola A, Plass W, Atolani O, Sugi T, Han Y, et al.
Parasitol Res . 2020 Apr; 119(6):1925-1941. PMID: 32279093
Toxoplasmosis is a common parasitic disease caused by Toxoplasma gondii. Limitations of available treatments motivate the search for better therapies for toxoplasmosis. In this study, we synthesized a series of...
6.
Adeyemi O, Molina M, Eseola A, Fonseca-Berzal C, Gomez-Barrio A
Comb Chem High Throughput Screen . 2017 Jan; 20(1):20-24. PMID: 28071587
Background: Current drugs available for the treatment of Chagas disease are fraught with several challenges including severe toxicity and limited efficacy. These factors coupled with the absence of effective drugs...
7.
Eseola A, Li W, Gao R, Zhang M, Hao X, Liang T, et al.
Inorg Chem . 2009 Sep; 48(19):9133-46. PMID: 19728689
A series of 2-(imidazole-2-yl)phenol ligands L1-L6 with the general composition 4-R(4)-5-R(3)-6-R(2)-2-(4,5-R(1),R(1)-1H-imidazole-2-yl)phenol (L1: R(1) = C(2)H(5), R(2) = R(3) = R(4) = H; L2: R(1) = C(6)H(5), R(2) = R(3) =...